Yuchen Zhong

Dr. Yuchen Zhong


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
YZYuchen Zhong
Yuchen Zhong
TMTianyi Ma
Tianyi Ma
TQTianyu Qiao
Tianyu Qiao
HHHanqing Hu
Hanqing Hu
ZLZhengliang Li
Zhengliang Li
XWXishan Wang
Xishan Wang
Objective: To investigate the relationship between circulating tumor cells (CTCs) and their subpopulations and colorectal cancer (CRC). To explore the application of CTCs’ numbers and positive rates in the diagnosis and treatment of CRC, and to assess the effect of surgery on CTCs numbers and positivity. Methods: We identified CTCs using the CanPatrol technique after enrollment. Peripheral blood samples were collected from 74 CRC patients before anti-tumor treatment. CTCs can be divided into the following three phenotypes: epithelial CTCs (E-CTCs) (EpCAM+, Vimentin-), mesenchymal CTCs (M-CTCs) (EpCAM-, Vimentin+), and mixed CTCs (E/M-CTCs) (EpCAM+, Vimentin+). CTCs and the proportion of subtypes were statistically compared with clinicopathological characteristics. Results: The positive rate of M-CTCs was significantly higher in patients with tumor size ≥ 5 cm (85.7% vs 49.1%, P = 0.004) and carcinoembryonic antigen (CEA) > 5 ng/mL (83.3% vs 51.0% p = 0.024). Moreover, the T stage (T1 0, T2 33.3%, T3 59.4%, T4 100%, p < 0.0005) and TNM stage (stage I 11.8%, stage II 79.2%, stage III 64.3%, stage IV 100%, p < 0.0005) were correlated with the positive rate of M-CTCs. We also found that the proportion of M-CTCs was correlated with the T stage (p < 0.0005) and TNM stage (p=0.0200), but not with the N stage (p=0.6889). In survival analysis, M-CTCs > 1 were found associated with worse disease-free survival (p=0.007). After treatment, the number and proportion of CTCs and M-CTCs were significantly reduced. Conclusion: The positive rate of M-CTCs was associated with tumor size, T stage, TNM stage, vascular invasion, and CEA. As the disease progressed, the proportion of M-CTCs gradually increased, and the survival performance was worse in patients with a high positive rate of M-CTCs.

7 June 2024 in Clinical and Translational Medicine
Verified
Journal Article
Open access
HZHao Zhang
Hao Zhang
ZCZewen Chang
Zewen Chang
CWChunlin Wang
Chunlin Wang
ZYZiming Yuan
Ziming Yuan
YLYunxiao Liu
Yunxiao Liu
GWGuiYu Wang
GuiYu Wang

31 March 2021 in Surgical Innovation
Verified
Journal Article
Closed access
PDF file
YZYuchen Zhong
Yuchen Zhong
TQTianyu Qiao
Tianyu Qiao
TMTianyi Ma
Tianyi Ma
HHHanqing Hu
Hanqing Hu
YJYinghu Jin
Yinghu Jin
XWXishan Wang
Xishan Wang
Objective. There are few studies comparing the long-term results of natural orifice specimen extraction surgery (NOSES) and conventional laparoscopic-assisted resection (LA) in the treatment of middle rectal cancer. This retrospective analysis aimed to evaluate the reliability of NOSES. Method. From January 2013 to December 2017, all patients diagnosed with median rectal cancer in our hospital who underwent NOSES and LA were enrolled. We used propensity-score matching (PSM) to balance baseline data between the NOSES group and the laparoscopic group. The primary endpoint was overall survival (OS) and disease-free survival (DFS). We used the Kaplan–Meier method to estimate OS and DFS. Student’s t-test was used to analyze the difference of continuous data. Categorical data were compared using the Kruskal–Wallis test or Fisher’s exact test. Results. After PSM, 38 patients were included in each group. We found that surgical bleeding volume in the NOSES group was considerably lower than that in the LA group (49.5 ± 47.5 mL vs. 86.3 ± 83.5 mL, P = .01). From the short-term results, the first flatus and regular diet time in the NOSES group were shorter than those in the LA group (41.3 ± 25.2 vs. 54.0 ± 19.2 hours, P < .01 and 63.9 ± 42.6 hours vs. 105.1 ± 66.8 hours, P < .01, respectively). Long-term OS and DFS were not different between the groups. Conclusion. Therefore, NOSES is a reliable technique for middle rectal cancer treatment. Short-term outcomes are pointedly better than LA, while the two surgical approaches did not differ in the long-term outcomes or complication rate.

7 March 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
YZYuchen Zhong
Yuchen Zhong
CZChaojing Zheng
Chaojing Zheng
ZWZitong Wang
Zitong Wang
WZWeiyuan Zhang
Weiyuan Zhang
HWHongyu Wu
Hongyu Wu
GWGuiYu Wang
GuiYu Wang
Colorectal cancer progression involves dysregulated signaling pathways such as Hippo-YAP, but upstream regulators remain poorly defined. Here we demonstrate that oxysterol-binding protein-like 3 (OSBPL3) modulates Hippo-YAP signaling to drive tumor aggressiveness. Analysis of clinical specimens and experimental models shows that elevated OSBPL3 levels in colorectal cancer tissues correlate with shortened patient survival. Depleting OSBPL3 impairs cancer cell proliferation and invasion and induces cell cycle arrest, while its overexpression accelerates tumor growth. Mechanistic studies reveal that OSBPL3 binds 14-3-3 proteins to promote YAP1 nuclear translocation, activating downstream oncogenic pathways. Notably, tumors with high OSBPL3 expression exhibit resistance to MEK inhibitors, but this resistance is overcome by YAP1 suppression or combined YAP/MEK inhibition in patient-derived organoids. These results establish OSBPL3 as a critical Hippo-YAP pathway regulator and propose targeting OSBPL3-mediated signaling as a therapeutic strategy for colorectal cancers with Hippo pathway alterations.

19 May 2026 in Advanced Science
Verified
Journal Article
Open access
CWChunlin Wang
Chunlin Wang
HWHongyu Wu
Hongyu Wu
CZChaojing Zheng
Chaojing Zheng
HZHao Zhang
Hao Zhang
XWXiaoqiu Wu
Xiaoqiu Wu
GWGuiyu Wang
Guiyu Wang
Colorectal cancer (CRC) poses a significant global health challenge, highlighting the need for better diagnostic tools and molecular targets. Compared to traditional antibodies, aptamers, which are single‐stranded oligonucleotides with high affinity and low immunogenicity, offer an ideal platform for discovering novel biomarkers. Based on this approach, we used the Cell‐SELEX strategy to develop a high‐affinity aptamer‐based probe, WHY‐3E, which successfully identified the cellular prion protein (PrPC) as a key molecular target. We observed that PrPC was significantly upregulated in CRC tissues, strongly correlating with unfavorable clinical outcomes. Functionally, PrPC promotes malignant phenotypes, including migration and invasion, by regulating MSN. Mechanistically, we revealed that PrPC physically translocates from the cell surface to the cytoplasm via endocytosis. Once internalized, it interacts with the STAT3‐NTD and LYN‐SH domains, facilitating the ternary complex formation that enhances LYN‐mediated STAT3 phosphorylation, ultimately increasing MSN transcriptional activity. Moreover, the deubiquitinase USP18 stabilizes PrPC by removing its Lys48‐linked ubiquitin chains, ensuring the continuous activation of this oncogenic axis. Notably, the WHY‐3E aptamer achieved 90.6% sensitivity and 89.0% specificity in detecting PrPC‐positive circulating exosomes in patient cohorts. These findings deepen the mechanistic understanding of CRC progression and offer novel strategic avenues for PrPC‐targeted aptamer applications in non‐invasive diagnostics.

24 April 2026 in Obesity Science & Practice
Verified
Journal Article
Open access
SLShuang Li
Shuang Li
YZYuchen Zhong
Yuchen Zhong
YLYan Liu
Yan Liu
MXMeixia Xiao
Meixia Xiao
SSShengming Shi
Shengming Shi
Objective: A Body Shape Index (BSI), previously developed and evaluated as an improvement over traditional adiposity measures for predicting health risks, has not been comprehensively characterized with respect to its temporal trends, population disparities, and prognostic value in the United States. Methods: This analysis examined data from 47,762 adults across 10 NHANES cycles (1999–2018). BSI trends were assessed across demographic and health‐related subgroups. All‐cause mortality risk was evaluated using Cox regression, with adjustment for multiple confounders. Interaction and restricted cubic spline analyses explored effect modification and nonlinearity. Results: Mean BSI increased significantly over the two decades. Disparities persisted or widened over time. Elevated BSI was independently associated with higher mortality risk, particularly above the median, with a nonlinear escalation in risk at higher BSI levels. The impact of high BSI on all‐cause mortality was stronger in males and varied by race/ethnicity, while lower BSI showed no protective effect. Conclusions: BSI demonstrates a rising trend and persistent disparities among U.S. adults, with high BSI independently predicting adverse all‐cause mortality in a nonlinear manner. These findings from the analyzed data supported the utility of BSI in risk stratification and highlighted the need for targeted interventions. Future research should explore BSI's role in public health strategies.